Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clint L Miller

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Frontiers in Cardiovascular Medicine|March 7, 2019
Multi-Omics Approaches to Study Long Non-coding RNA Function in AtherosclerosisAdam W Turner, Doris Wong, Mohammad Daud Khan, et al.
Circulation|June 6, 2019
Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan SyndromeFabrice Jaffré, Clint L Miller, Anne Schänzer, et al.
Basic Research in Cardiology|October 21, 2011
Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heartClint L Miller, Yujun Cai, Masayoshi Oikawa, et al.
Journal of the American College of Cardiology|May 21, 2021
Precision Medicine Approaches to Vascular Disease: JACC Focus Seminar 2/5Clint L Miller, Amy R Kontorovich, Ke Hao, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 15, 2010
Cyclic nucleotide phosphodiesterase 1 regulates lysosome-dependent type I collagen protein degradation in vascular smooth muscle cellsYujun Cai, Clint L Miller, David J Nagel, et al.
Genome Medicine|April 25, 2019
TCF21 and AP-1 interact through epigenetic modifications to regulate coronary artery disease gene expressionQuanyi Zhao, Robert Wirka, Trieu Nguyen, et al.
Nature Communications|December 1, 2025
Interferon dependent immune memory during HSV-1 neuronal latency via increased H3K9me3 and restriction by ATRXAbigail L Whitford, Gaelle Auguste, Alison K Francois, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 27, 2025
The 9p21.3 Coronary Artery Disease Risk Locus Drives Vascular Smooth Muscle Cells to an Osteochondrogenic StateElsa Salido, Carolina de Medeiros Vieira, Jose Verdezoto Mosquera, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
The 9p21.3 coronary artery disease risk locus drives vascular smooth muscle cells to an osteochondrogenic stateElsa Salido, Carolina de Medeiros Vieira, José Verdezoto Mosquera, et al.
The FEBS Journal|November 17, 2010
Ca2+/calmodulin-stimulated PDE1 regulates the beta-catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cellsKye-Im Jeon, Hirofumi Jono, Clint L Miller, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Frontiers in Cardiovascular Medicine|March 7, 2019
Multi-Omics Approaches to Study Long Non-coding RNA Function in AtherosclerosisAdam W Turner, Doris Wong, Mohammad Daud Khan, et al.
Circulation|June 6, 2019
Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan SyndromeFabrice Jaffré, Clint L Miller, Anne Schänzer, et al.
Basic Research in Cardiology|October 21, 2011
Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heartClint L Miller, Yujun Cai, Masayoshi Oikawa, et al.
Journal of the American College of Cardiology|May 21, 2021
Precision Medicine Approaches to Vascular Disease: JACC Focus Seminar 2/5Clint L Miller, Amy R Kontorovich, Ke Hao, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 15, 2010
Cyclic nucleotide phosphodiesterase 1 regulates lysosome-dependent type I collagen protein degradation in vascular smooth muscle cellsYujun Cai, Clint L Miller, David J Nagel, et al.
Genome Medicine|April 25, 2019
TCF21 and AP-1 interact through epigenetic modifications to regulate coronary artery disease gene expressionQuanyi Zhao, Robert Wirka, Trieu Nguyen, et al.
Nature Communications|December 1, 2025
Interferon dependent immune memory during HSV-1 neuronal latency via increased H3K9me3 and restriction by ATRXAbigail L Whitford, Gaelle Auguste, Alison K Francois, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 27, 2025
The 9p21.3 Coronary Artery Disease Risk Locus Drives Vascular Smooth Muscle Cells to an Osteochondrogenic StateElsa Salido, Carolina de Medeiros Vieira, Jose Verdezoto Mosquera, et al.
Biorxiv : the Preprint Server for Biology|June 10, 2024
The 9p21.3 coronary artery disease risk locus drives vascular smooth muscle cells to an osteochondrogenic stateElsa Salido, Carolina de Medeiros Vieira, José Verdezoto Mosquera, et al.
The FEBS Journal|November 17, 2010
Ca2+/calmodulin-stimulated PDE1 regulates the beta-catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cellsKye-Im Jeon, Hirofumi Jono, Clint L Miller, et al.
Pageof 11